RAFA — Rafarma Pharmaceuticals, Inc.

RAFA

SHORT CANDIDATEMeanRev

Composite

29.40

Technical

13.30

Fundamental

34.80

Rank

—

Price

0.04

Hurst

0.39

As of

Jul 13, 2026

Daily

Rafarma Pharmaceuticals, Inc.

HealthcareDrug Manufacturers - Specialty & Generic

Rafarma Pharmaceuticals manufactures and distributes medical devices for use in hospital and clinical settings. Based in Draper, Utah and incorporated in 1982, the company operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd. as of October 2020.

Market cap

$1.5M

P/E (trailing)

—

P/E (forward)

—

PEG ratio

—

Dividend yield

0.00%

Beta

0.72

52w range

0.00 – 0.09

Return on equity

-0.07%

Profit margin

-87.92%

Revenue growth

—

Earnings growth

—

Price history

1Y: 0.02 (-54.0%) · range 0.01–0.09

Cycle position

0/ 100 cycle scoreENTRY ZONE

ENTRYAPPROACHMID-BULLNEAR-TOPEXIT

entry readiness 80 · STRONG SETUP · exit proximity 0

Conviction

43/ 100 · maturity 0%

Buildup.334

EMA entry setup.4280

Fundamentals.2535

Volume profile

POC

0.02

Price vs POC

-30.6%

Overhead supply

96%

Runway

+14.7%

Value area 0.02–0.03 · 96% of 56d volume overhead · heavy supply

Contributing sources

No source detections in the last 21 days.

Forward returns

Horizon	Return	MFE	State
20d	0.00%	0.00%	1/20d
40d	0.00%	0.00%	1/40d